AI Assistant
Blog
Pricing
Log In
Sign Up
Time to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of survival
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
